Syed Rizvi

5.3k total citations · 1 hit paper
83 papers, 1.9k citations indexed

About

Syed Rizvi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Syed Rizvi has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 24 papers in Pathology and Forensic Medicine and 23 papers in Hematology. Recurrent topics in Syed Rizvi's work include Histone Deacetylase Inhibitors Research (24 papers), Multiple Sclerosis Research Studies (16 papers) and Multiple Myeloma Research and Treatments (16 papers). Syed Rizvi is often cited by papers focused on Histone Deacetylase Inhibitors Research (24 papers), Multiple Sclerosis Research Studies (16 papers) and Multiple Myeloma Research and Treatments (16 papers). Syed Rizvi collaborates with scholars based in United States, Japan and Belgium. Syed Rizvi's co-authors include Lauren Krupp, David S. Siegel, Mark Agius, J. Garcia‐Vargas, Justin L. Ricker, César Sanz-Rodrı́guez, Victoria M. Richon, Atsushi Ohtsu, Kun‐Huei Yeh and Keisho Chìn and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Syed Rizvi

76 papers receiving 1.8k citations

Hit Papers

Everolimus for Previously Treated Advanced Gastric Cancer... 2013 2026 2017 2021 2013 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Syed Rizvi United States 20 840 666 587 412 325 83 1.9k
Vasiliki Pappa Greece 25 644 0.8× 285 0.4× 344 0.6× 331 0.8× 134 0.4× 109 1.7k
Maria Christina Cox Italy 30 850 1.0× 842 1.3× 743 1.3× 1.2k 3.0× 173 0.5× 111 2.8k
Jin Sun Lee South Korea 28 454 0.5× 758 1.1× 119 0.2× 362 0.9× 584 1.8× 101 2.1k
Hannah Briemberg Canada 15 626 0.7× 458 0.7× 86 0.1× 528 1.3× 53 0.2× 32 1.7k
Marleen Renard Belgium 21 347 0.4× 333 0.5× 279 0.5× 73 0.2× 234 0.7× 50 1.5k
Suzan Zorludemir Türkiye 20 304 0.4× 202 0.3× 134 0.2× 280 0.7× 216 0.7× 89 1.3k
Francisco Bautista Spain 18 329 0.4× 247 0.4× 81 0.1× 144 0.3× 163 0.5× 74 1.1k
Jonathan S. Harrison United States 22 590 0.7× 310 0.5× 177 0.3× 282 0.7× 158 0.5× 73 1.6k
Kenji Hashimoto Japan 19 289 0.3× 568 0.9× 58 0.1× 67 0.2× 248 0.8× 54 1.1k
Xiaoqiang Han United States 14 213 0.3× 132 0.2× 422 0.7× 118 0.3× 80 0.2× 24 950

Countries citing papers authored by Syed Rizvi

Since Specialization
Citations

This map shows the geographic impact of Syed Rizvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Syed Rizvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Syed Rizvi more than expected).

Fields of papers citing papers by Syed Rizvi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Syed Rizvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Syed Rizvi. The network helps show where Syed Rizvi may publish in the future.

Co-authorship network of co-authors of Syed Rizvi

This figure shows the co-authorship network connecting the top 25 collaborators of Syed Rizvi. A scholar is included among the top collaborators of Syed Rizvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Syed Rizvi. Syed Rizvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rizvi, Syed, et al.. (2025). Progressive multiple sclerosis: Evaluating current therapies and exploring future treatment strategies. Neurotherapeutics. 22(4). e00601–e00601. 3 indexed citations
3.
Rizvi, Syed, et al.. (2024). Varicella Zoster Associated Vasculopathy and Retinitis with Natalizumab Use in Multiple Sclerosis.. PubMed. 107(1). 26–28.
4.
5.
Rizvi, Syed, et al.. (2024). Optimizing Healthcare Outcomes through Data-Driven Predictive Modeling. 16(4). 384–402. 6 indexed citations
6.
Rizvi, Syed, et al.. (2021). Efficacy of Short Course of Preksha Dhyana for Functional Abdominal Pain Disorder in a Busy Pediatric Clinic. Frontiers in Pediatrics. 9. 646686–646686. 3 indexed citations
7.
Rizvi, Syed, et al.. (2020). Acute Liver Failure in a Sickle Cell Patient. Journal of Pediatric Gastroenterology and Nutrition. 72(2). e54–e55. 2 indexed citations
9.
Rizvi, Syed. (2019). Neurological Complications of Lyme Disease. Definitions. 91(7). 216–8.
10.
Rizvi, Syed, et al.. (2019). Deep Neural Net Forecasting of Multiple Sclerosis Disease Severity (P3.2-013). Neurology. 92(15_supplement). 1 indexed citations
11.
Cahill, Jonathan, et al.. (2018). Multiple sclerosis relapse presenting as an acute cardiomyopathy. Multiple Sclerosis and Related Disorders. 27. 7–8. 12 indexed citations
12.
Rizvi, Syed, et al.. (2015). Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor. Parkinsonism & Related Disorders. 21(10). 1145–1147. 6 indexed citations
13.
Rizvi, Syed, et al.. (2015). The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis. Parkinsonism & Related Disorders. 21(9). 1093–1095. 26 indexed citations
14.
Chintakuntlawar, Ashish V., Syed Rizvi, Stephen D. Cassivi, & Animesh Pardanani. (2014). Thymoma-associated pancytopenia: immunosuppressive therapy is the cornerstone for durable hematological remission. Annals of Hematology. 94(3). 453–458. 7 indexed citations
16.
Siegel, David S., Mohamad A. Hussein, Chandra P. Belani, et al.. (2009). Vorinostat in solid and hematologic malignancies. Journal of Hematology & Oncology. 2(1). 31–31. 151 indexed citations
17.
Dummer, Reinhard, Kenneth B. Hymes, Wolfram Sterry, et al.. (2009). Vorinostat in combination with bexarotene in advanced cutaneous T-cell lymphoma: A phase I study. Journal of Clinical Oncology. 27(15_suppl). 8572–8572. 15 indexed citations
18.
Richardson, Paul G., Constantine Mitsiades, Kathleen Colson, et al.. (2008). Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma. Leukemia & lymphoma. 49(3). 502–507. 167 indexed citations
19.
Rizvi, Syed. (2007). Multiple Sclerosis: Current and Future Treatment Options. Endocrine Metabolic & Immune Disorders - Drug Targets. 7(4). 292–299. 3 indexed citations
20.
Parsonnet, Victor, et al.. (2001). Laser Extraction of Entrapped Leads. Pacing and Clinical Electrophysiology. 24(3). 329–332. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026